Phase 1b Study of Abiraterone Acetate Plus Prednisone and Docetaxel in Patients with Metastatic Castration-resistant Prostate Cancer
Tagawa ST, Posadas EM, Bruce J, Lim EA, Petrylak DP, Peng W, Kheoh T, Maul S, Smit JW, Gonzalez MD, De Porre P, Tran N, Nanus DM, Eur Urol., 1/3/2016Increased survival with enzalutamide in prostate cancer after chemotherapy
Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, de Wit R, Mulders P, Chi KN, Shore ND, Armstrong AJ, Flaig TW, Flechon A, Mainwaring P, Fleming M, Hains..., N Engl J Med, 1/1/2012Presurgical Therapy for Renal Cell Carcinoma and Implications for Window of Opportunity Trials
Kim, H.L., Posadas, E.M., Figlin RA, Renal Cell Carcinoma: Biology, Prognostic Factors, and Therapeutic targets, 1/1/2011ncG1vNJzZmivp6x7pbvXoqSirKljsLC5jqmsm2eVmcSquoyppqyZlJbAbrnD